Comments
Loading...

AnaptysBio

ANABNASDAQ
Logo brought to you by Benzinga Data
$36.57
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$80.00
Lowest Price Target1
$21.00
Consensus Price Target1
$47.64

AnaptysBio (NASDAQ:ANAB) Stock, Analyst Ratings, Price Targets, Forecasts

AnaptysBio Inc has a consensus price target of $47.64 based on the ratings of 15 analysts. The high is $80 issued by Piper Sandler on February 16, 2024. The low is $21 issued by UBS on November 2, 2023. The 3 most-recent analyst ratings were released by Truist Securities, HC Wainwright & Co., and JP Morgan on August 15, 2024, August 14, 2024, and August 7, 2024, respectively. With an average price target of $53.33 between Truist Securities, HC Wainwright & Co., and JP Morgan, there's an implied 45.84% upside for AnaptysBio Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
Apr
1
May
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Truist Securities
HC Wainwright & Co.
JP Morgan
Wedbush
Leerink Partners

1calculated from analyst ratings

Analyst Ratings for AnaptysBio

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for AnaptysBio (ANAB) stock?

A

The latest price target for AnaptysBio (NASDAQ:ANAB) was reported by Truist Securities on August 15, 2024. The analyst firm set a price target for $30.00 expecting ANAB to fall to within 12 months (a possible -17.97% downside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for AnaptysBio (ANAB)?

A

The latest analyst rating for AnaptysBio (NASDAQ:ANAB) was provided by Truist Securities, and AnaptysBio maintained their hold rating.

Q

When was the last upgrade for AnaptysBio (ANAB)?

A

The last upgrade for AnaptysBio Inc happened on July 19, 2024 when JP Morgan raised their price target to $69. JP Morgan previously had a neutral for AnaptysBio Inc.

Q

When was the last downgrade for AnaptysBio (ANAB)?

A

The last downgrade for AnaptysBio Inc happened on January 6, 2023 when Raymond James changed their price target from N/A to N/A for AnaptysBio Inc.

Q

When is the next analyst rating going to be posted or updated for AnaptysBio (ANAB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AnaptysBio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AnaptysBio was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

Q

Is the Analyst Rating AnaptysBio (ANAB) correct?

A

While ratings are subjective and will change, the latest AnaptysBio (ANAB) rating was a maintained with a price target of $20.00 to $30.00. The current price AnaptysBio (ANAB) is trading at is $36.57, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch